Therapy-related myeloid sarcoma with an NPM1 mutation

被引：4

作者：

Bhatta, Sumita ^{[1
]}

Kut, Victoria ^{[3
]}

Petronic-Rosic, Vesna ^{[1
]}

Hyjek, Elizabeth ^{[2
]}

Larson, Richard A. ^{[1
]}

机构：

[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA

[2] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA

[3] NW Lake Forest Hosp, Dept Med, Chicago, IL USA

来源：

LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 11期

关键词：

ADULT PATIENTS; LEUKEMIA; FEATURES; AML;

D O I：

10.3109/10428194.2010.509454

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2130 / 2131

页数：2

共 7 条

[1] NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features [J].

Andersen, M. T. ;

Andersen, M. K. ;

Christiansen, D. H. ;

Pedersen-Bjergaard, J. .

LEUKEMIA, 2008, 22 (05) :951-955

[2] Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas [J].

Falini, B. ;

Lenze, D. ;

Hasserjian, R. ;

Coupland, S. ;

Jaehne, D. ;

Soupir, C. ;

Liso, A. ;

Martelli, M. P. ;

Bolli, N. ;

Bacci, F. ;

Pettirossi, V. ;

Santucci, A. ;

Martelli, M. F. ;

Pileri, S. ;

Stein, H. .

LEUKEMIA, 2007, 21 (07) :1566-1570

[3] Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features [J].

Falini, Brunangelo ;

Nicoletti, Ildo ;

Martelli, Massimo F. ;

Mecucci, Cristina .

BLOOD, 2007, 109 (03) :874-885

[4] Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients [J].

Pileri, S. A. ;

Ascani, S. ;

Cox, M. C. ;

Campidelli, C. ;

Bacci, F. ;

Piccioli, M. ;

Piccaluga, P. P. ;

Agostinelli, C. ;

Asioli, S. ;

Novero, D. ;

Bisceglia, M. ;

Ponzoni, M. ;

Gentile, A. ;

Rinaldi, P. ;

Franco, V. ;

Vincelli, D. ;

Pileri, A., Jr. ;

Gasbarra, R. ;

Falini, B. ;

Zinzani, P. L. ;

Baccarani, M. .

LEUKEMIA, 2007, 21 (02) :340-350

[5] Nucleophosmin gene mutations are predictors of favourable prognosis in acute myeloid leukemia with a normal kayotype and can be used as a new marker for quantitative PCR to detect minimal residual [J].

Schnittger, S ;

Schoch, C ;

Kern, W ;

Mecucci, C ;

Tschulik, C ;

Martelli, MF ;

Hiddemann, W ;

Haferlach, T ;

Falini, B .

BLOOD, 2005, 106 (11) :68A-69A

[6] Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) [J].

Thiede, Christian ;

Koch, Sina ;

Creutzig, Eva ;

Steudel, Christine ;

Illmer, Thomas ;

Schaich, Markus ;

Ehninger, Gerhard .

BLOOD, 2006, 107 (10) :4011-4020

[7]

Vardiman JW., 2008, WHO CLASSIFICATION T

← 1 →